ScholarIQanswers from OpenAlex & ORCID
Robyn J. Barst
ResearcherPublications, citations & collaboration network
Robyn J. Barst is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robyn J. Barst have?
ScholarIQindexed works
Robyn J. Barst has 348 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robyn J. Barst have?
ScholarIQcitation count
Robyn J. Barst has 55,398 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robyn J. Barst?
ScholarIQh-index
Robyn J. Barst has an h-index of 102 in OpenAlex.
What is the i10-index of Robyn J. Barst?
ScholarIQi10-index
Robyn J. Barst has an i10-index of 217 in OpenAlex.
What is the OpenAlex record for Robyn J. Barst?
ScholarIQopenalex
The OpenAlex for Robyn J. Barst is on the source record.
What are the most-cited papers on Robyn J. Barst?
ScholarIQmost cited works
Bosentan Therapy for Pulmonary Arterial Hypertension
Lewis J. Rubin, David B. Badesch, Robyn J. Barst, Nazzareno Galiè, Carol M. Black, Anne Keogh, Tomás Pulido, Adaani Frost, Sébastiên Roux, Isabelle Leconte, Michael J. Landzberg, Gérald Simonneau
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
Robyn J. Barst, Lewis J. Rubin, Walker Long, Michael D. McGoon, Stuart Rich, David B. Badesch, Bertron Μ. Groves, Victor F. Tapson, Robert C. Bourge, Bruce H. Brundage, Spencer K. Koerner, David Langleben, Cesar A. Keller, Srinivas Murali, Barry F. Uretsky, Linda Clayton, Maria M. Jöbsis, Shelmer D. Blackburn, Denise Shortino, James W. Crow
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial
Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè, Robert Naeije, Stuart Rich, Robert C. Bourge, Anne Keogh, Ronald J. Oudiz, Adaani Frost, Shelmer D. Blackburn, James W. Crow, Lewis J. Rubin
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin, Fredrick M. Wigley, Stuart Rich, Robyn J. Barst, Pamela S. Barrett, Kenneth M. Kral, Maria M. Jöbsis, James E. Loyd, Srinivas Murali, Adaani Frost, Reda E. Girgis, Robert C. Bourge, David Ralph, C. Gregory Elliott, Nicholas S. Hill, David Langleben, Robert Schilz, Vallerie V. McLaughlin, Ivan M. Robbins, Bertron Μ. Groves, Shelley Shapiro, Thomas A. Medsger, Seán Gaine, Evelyn M. Horn, James C. Decker, Katharine Knobil
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
Vallerie V. McLaughlin, Ronald J. Oudiz, Adaani Frost, Victor F. Tapson, Srinivas Murali, Richard N. Channick, David B. Badesch, Robyn J. Barst, Henry H. Hsu, Lewis J. Rubin